Polypill to prevent heart failure in diabetes and kidney disease
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a 'polypill' (a combination of several medicines in one pill) to prevent heart failure in people with type 2 diabetes and kidney disease. It may help reduce your risk of developing heart muscle problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- You have chronic kidney disease (stage 2, 3, or 4, meaning your kidney function is moderately reduced).
- You are at high risk for heart failure, or you have high levels of certain heart stress markers, or your heart muscle is thickened.
- You do not have congestive heart failure or high potassium levels (above 5.0).
- You are not pregnant and can exercise for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
This study tests a single pill that combines three heart medicines—aspirin, a blood thinner, and a statin—to see if it helps people who have had a heart attack or stent procedure. It aims to make it easier to take your daily heart medications.
This trial tests a single 'polypill' that combines several medicines for people with high blood pressure, high cholesterol, and type 2 diabetes. The goal is to see if taking one pill each day helps control these conditions better than usual care.
This study tests a single pill that combines several heart failure medicines to see if it helps people with a weakened heart pump feel better and stay out of the hospital. It is being done in Sri Lanka and may offer a simpler way to take multiple medications.
This Phase 3 trial tests whether a daily “polypill” can reduce the chance of another stroke after a recent ischemic stroke. It may help people by improving several heart-and-blood-vessel risks at once, but only if it fits safely with their medical situation.
This trial looks at how a daily “polypill” affects coronary (heart blood vessel) risk factors in adults who already take this polypill for prevention after a prior heart event. If you’re eligible, you’ll complete several study visits so the team can compare risk factors over time.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.